PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics

Pharmacogenet Genomics. 2020 Jun;30(4):81-90. doi: 10.1097/FPC.0000000000000397.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ATP-Binding Cassette Transporters / genetics*
  • ATP-Binding Cassette Transporters / metabolism
  • Anticonvulsants / adverse effects
  • Anticonvulsants / pharmacokinetics*
  • Anticonvulsants / pharmacology*
  • Brain / metabolism*
  • Calcium Channels, Q-Type / genetics
  • Calcium Channels, Q-Type / metabolism
  • Humans
  • Lamotrigine / adverse effects
  • Lamotrigine / pharmacokinetics*
  • Lamotrigine / pharmacology*
  • Monosaccharide Transport Proteins / genetics*
  • Monosaccharide Transport Proteins / metabolism
  • Polymorphism, Genetic
  • Receptors, GABA / genetics*
  • Receptors, GABA / metabolism

Substances

  • ATP-Binding Cassette Transporters
  • Anticonvulsants
  • Calcium Channels, Q-Type
  • Monosaccharide Transport Proteins
  • Receptors, GABA
  • UDP-galactose translocator
  • Lamotrigine